AstraZeneca Pauses COVID-19 Vaccine Trial


A COVID-19 vaccine trial participant contracted an inflammatory syndrome that affects the spinal cord. Unsure how it is linked to AstraZeneca’s vaccine.

Drugmaker Pauses Covid-19 Vaccine Trial for Safety Review



The pharmaceutical company AstraZeneca halted global trials of its coronavirus vaccine on Tuesday because of a serious and unexpected adverse reaction in a participant, the company said.

A person familiar with the situation, and who spoke on the condition of anonymity, said that the participant had been enrolled in a Phase 2/3 trial based in the United Kingdom. The individual also said that a volunteer in the U.K. trial had been found to have transverse myelitis ...



Home Health Columnist / Guide


11 Articles; 17,702 Posts

Specializes in Vents, Telemetry, Home Care, Home infusion. Has 46 years experience.

Bloomberg News  9/09/2020

AstraZeneca Study Halted After Spinal-Cord Issue, NIH Chief Says




U.S. National Institutes of Health Director Francis Collins told a Senate committee Wednesday that AstraZeneca Plc’s closely watched Covid-19 vaccine trial had been halted due to a “spinal cord problem.” ...

...Appearing before the Senate Committee on Health, Education, Labor & Pensions, Collins said that the severe adverse event in question was transverse myelitis, a neurological disorder that causes inflammation of the spinal cord. If AstraZeneca’s review finds the adverse event is related to the vaccine, all the doses already manufactured will be thrown away, Collins said....